참고문헌
- Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003;290:2581-2587. https://doi.org/10.1001/jama.290.19.2581
- Kearney MT, Fox KA, Lee AJ, et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol 2002;40:1801-1808. https://doi.org/10.1016/S0735-1097(02)02490-7
- Senni M, De Maria R, Gregori D, et al. Temporal trends in survival and hospitalizations in outpatients with chronic systolic heart failure in 1995 and 1999. J Card Fail 2005;11:270-278. https://doi.org/10.1016/j.cardfail.2004.11.003
- Harjola VP, Follath F, Nieminen MS, et al. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail 2010;12:239-248. https://doi.org/10.1093/eurjhf/hfq002
- Gheorghiade M, Gattis WA, O’Connor CM, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 2004;291:1963-1971. https://doi.org/10.1001/jama.291.16.1963
- Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007;28:980-988. https://doi.org/10.1093/eurheartj/ehl542
- Klein L, O'Connor CM, Leimberger JD, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation 2005;111:2454-2460. https://doi.org/10.1161/01.CIR.0000165065.82609.3D
- Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 2008;52:347-356. https://doi.org/10.1016/j.jacc.2008.04.028
- Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999;341:577-585. https://doi.org/10.1056/NEJM199908193410806
- Schrier RW, Berl T. Mechanism of effect of alpha adrenergic stimulation with norepinephrine on renal water excretion. J Clin Invest 1973;52:502-511. https://doi.org/10.1172/JCI107207
- Schrier RW, Berl T, Anderson RJ. Osmotic and non-osmotic control of vasopressin release. Am J Physiol 1979;236:F321-F332.
- Goldsmith SR, Francis GS, Cowley AW Jr. Arginine vasopressin and the renal response to water loading in congestive heart failure. Am J Cardiol 1986;58:295-299. https://doi.org/10.1016/0002-9149(86)90065-2
- Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006;355:2099-2112. https://doi.org/10.1056/NEJMoa065181
- Udelson JE, McGrew FA, Flores E, et al. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction. J Am Coll Cardiol 2007;49:2151-2159. https://doi.org/10.1016/j.jacc.2007.01.091
- Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007;297:1319-1331. https://doi.org/10.1001/jama.297.12.1319
- Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting- enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;73:257-267. https://doi.org/10.1161/01.CIR.73.2.257
- Packer M, Medina N, Yushak M. Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure. J Am Coll Cardiol 1984;3:1035-1043. https://doi.org/10.1016/S0735-1097(84)80364-2
- Riegger GA, Kochsiek K. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 1986;58:300-303. https://doi.org/10.1016/0002-9149(86)90066-4
- Packer M, Lee WH, Kessler PD, Medina N, Yushak M, Gottlieb SS. Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure. J Am Coll Cardiol 1987;10:837-844. https://doi.org/10.1016/S0735-1097(87)80278-4
- Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:1977-2016. https://doi.org/10.1161/CIRCULATIONAHA.109.192064
- Lee SE, Choi DJ, Yoon CH, et al. Improvement of hyponatraemia during hospitalisation for acute heart failure is not associated with improvement of prognosis: an analysis from the Korean Heart Failure (KorHF) registry. Heart 2012;98:1798-1804. https://doi.org/10.1136/heartjnl-2012-302334
피인용 문헌
- Impact of hyponatremia on mortality and morbidity in patients with COPD exacerbations vol.117, pp.None, 2015, https://doi.org/10.1016/j.rmed.2016.05.003
- Gap Between Clinical Practice and Guidelines: A National Survey of the Knowledge of Recommended Heart Failure Guidelines Among Chinese Physicians vol.26, pp.4, 2017, https://doi.org/10.1097/qmh.0000000000000150
- Racial differences and mortality risk in patients with heart failure and hyponatremia vol.14, pp.6, 2015, https://doi.org/10.1371/journal.pone.0218504
- Hyponatremia in Heart Failure: Pathogenesis and Management vol.15, pp.4, 2015, https://doi.org/10.2174/1573403x15666190306111812
- Gender difference in the impact of Ischaemic heart disease on heart failure vol.50, pp.5, 2015, https://doi.org/10.1111/eci.13232
- Prognostic value of serum hyponatremia for outcomes in patients with heart failure with preserved ejection fraction: An observational cohort study vol.20, pp.5, 2015, https://doi.org/10.3892/etm.2020.9231
- Hyponatremia and Renal Venous Congestion in Heart Failure Patients vol.2021, pp.None, 2015, https://doi.org/10.1155/2021/6499346
- Laboratory prognostic score for predicting 14-day mortality in terminally ill patients with gynecologic malignancy vol.26, pp.7, 2015, https://doi.org/10.1007/s10147-021-01923-x
- A non-linear ensemble model-based surgical risk calculator for mixed data from multiple surgical fields vol.21, pp.suppl2, 2015, https://doi.org/10.1186/s12911-021-01450-9